|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/53 | |
| G01N 33/567 | |||
| G01N 33/573 | |||
| A61K 31/435 |
| (11) | Patento numeris | 2955520 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15173515.6 |
| Europos patento paraiškos padavimo data | 2007-05-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 801089 P | 2006-05-16 | US | |
| 853631 P | 2006-10-23 | US |
| (72) |
LOCKHART, David, US
CASTELLI, Jeff, US
|
| (73) |
Amicus Therapeutics, Inc.,
1 Cedar Brook Drive, Cranbury, NJ 08512,
US
NATIONAL INSTITUTES OF HEALTH, 10 Center Drive, Bethesda, MD 20892-1260, US |
| (54) | TREATMENT OPTIONS FOR FABRY DISEASE |
| TREATMENT OPTIONS FOR FABRY DISEASE |